The bill strengthens law-enforcement tools and transparency to disrupt deadly synthetic-drug distribution but does so by expanding data collection, mandatory preservation and reporting obligations that raise significant privacy, cost, and error risks for users and technology providers.
Law enforcement agencies and communities: providers will send structured, timely reports that help identify and disrupt fentanyl, methamphetamine, counterfeit drugs, and illegal prescription schemes, which can reduce local availability of deadly synthetic drugs and drug-related harms.
Platform operators and their employees: the bill provides a legal safe-harbor for providers acting in good faith when reporting suspected illegal drug activity, lowering their liability risk for cooperating with the program.
Taxpayers and the public: DOJ must publish annual reports on program use and outcomes, increasing transparency about report volume, uses, and enforcement results.
Everyday users and communities: users’ communications metadata and contextual data may be collected and widely shared with federal, state, local, tribal, and foreign agencies, substantially increasing surveillance and privacy risks and the chance of cross‑jurisdictional exposure.
Platform operators and small providers: the law imposes significant compliance, recordkeeping, and enforcement risks (including civil/criminal penalties up to $380,000), which could raise operating costs, increase prices for users, or threaten smaller services' viability.
Users and defendants: mandatory short-term preservation orders combined with gag-like notice restrictions delay or prevent timely notification to affected users, reducing transparency and complicating legal defense or civil-rights responses.
Based on analysis of 3 sections of legislative text.
Requires electronic communication and remote computing providers to report to the Attorney General/DEA when they know accounts/devices were used to facilitate certain controlled-substance offenses, with timelines, recordkeeping, and penalties.
Introduced July 17, 2025 by Roger Wayne Marshall · Last progress July 17, 2025
Requires providers of electronic communication services and remote computing services to notify the Attorney General and DEA when they obtain actual knowledge that an account, device, or service was used to facilitate manufacture, distribution, or possession with intent to distribute certain controlled substances (including fentanyl, methamphetamine, counterfeit prescription drugs, and unauthorized creation/distribution of prescription stimulants or pain medications). Reports must be made as soon as reasonably possible and no later than 60 days, include specified content and contact information, and indicate whether the discovery came from human review or automated systems. Sets recordkeeping and preservation rules, creates a safe-harbor for good-faith reporting, provides confidentiality protections, authorizes the Attorney General and DEA to issue regulations and use reported information for investigations and prosecutions, and creates civil penalty authority plus an administrative process for willful noncompliance. Includes a standard severability provision so other provisions remain in force if one is struck down.